XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
OPERATING ACTIVITIES:        
Net income (loss) $ (193,297) $ 2,756,900 $ 250,059 $ 526,230
Adjustment to reconcile net loss to net cash provided by operating activities:        
Net acquisition of FTT     25,000
Derivative liability (gain) loss (2,543,902) (1,545,336)
Gain on sale of assets (180,378) (180,378)
Depreciation 14,262 9,273 26,258 11,869
Issuance of Series L Preferred Stock for consulting services     250,000
Amortization of debt discounts 692,603
Changes in operating assets and liabilities:        
Accounts receivable     (266,046) (126,688)
Accounts payable     325,841 54,282
Accrued interest     24,727 94,161
Accrued director’s compensation     (58,333) 58,333
Net cash provided (used) by operating activities     302,506 (139,924)
INVESTING ACTIVITIES:        
Net cash provided (used) by investing activities (Software Dev)     (238,000)
FINANCING ACTIVITIES:        
Borrowings from loans payable, related parties, net     186,199
Payments on notes payable     (115,000)
Payments on loans, related party     (35,340)
Borrowings from convertible notes payable     45,000
Borrowings from loans payable-officer     5,000
Proceeds from sale of Series L Preferred Stock     30,000
Net cash provided (used) by financing activities     (150,340) 266,199
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS     (85,834) 126,275
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD     115,747 18,300
CASH AND CASH EQUIVALENTS, END OF PERIOD $ 29,913 $ 144,575 29,913 144,575
Supplemental Disclosures of Cash Flow Information:        
Taxes paid    
Interest paid    
Non-cash investing and financing activities:        
Accrual for contingent consideration of acquisition of GOe3, LLC     5,764,227
Issuance of preferred stock for asset purchase     $ 125,000